Recent Partnerships Abveris has established partnerships with companies like Enzolytics, Inc. to develop monoclonal antibodies against viruses, presenting a sales opportunity to collaborate on antibody discovery projects.

Acquisition by Twist Bioscience Twist Bioscience's acquisition of Abveris has expanded its capabilities in antibody design and discovery, creating potential sales opportunities for pharmaceutical and industrial clients seeking antibody-based solutions.

SARS-CoV-2 Antibody Sequences Abveris released antibody sequences specific to the SARS-CoV-2 spike protein for unrestricted use, offering sales prospects for organizations in need of COVID-19 research and therapeutic antibody development.

Industry Recognitions Abveris' recognition as one of the best places to work and awards for antibody development signify credibility and excellence, attributing to potential sales opportunities through trust and quality services.

Focused Biotechnology Research As a leader in in vivo antibody discovery, Abveris's specialization in biotechnology research positions them as a valuable partner for clients seeking innovative antibody solutions in various pharmaceutical and industrial applications.